Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Is Axillary Dissection Necessary for Breast Cancer in Old Women? A Meta-analysis of Randomized Clinical Trials

  • Zhang, Pei-Zhen (The Maternity & Infant Health Hospital of Lanzhou City) ;
  • Chong, Le (Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University) ;
  • Zhao, Ye (Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University) ;
  • Gu, Jing (Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University) ;
  • Tian, Jin-Hui (Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University) ;
  • Yang, Ke-Hu (Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University)
  • Published : 2013.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Background: We performed this meta-analysis to assess the effectiveness and safety of axillary dissection in old women. Methods: The Cochrane Library, PubMed, EMBASE and Chinese Biomedical Literature Database were searched and all randomized controlled trials of axillary dissection in old women (at least 60 years old) were considered. Meta-analyses were completed using RevMan5.1. Results: Three eligible randomized controlled trials (RCTs) including 5,337 patients were considered. There was weak evidence in favour of axillary dissection (AD) in old women. The meta-analysis showed that the overall survival (OS) after 1, 3, 5 and 7 years and the disease free survival (DFS) after 1, 3 and 5 year were not statistically significantly different between AD and no AD groups. However, there was a difference in the 7 year DFS. Conclusions: Axillary dissection did not provide survival benefit to the old women with breast cancer analysed. Therefore, axillary dissection is not well-indicated in old women with breast cancer.

Keywords

References

  1. Anderson BO, Shyyan R, Eniu A, et al (2006). Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J, 12, 3-15. https://doi.org/10.1111/j.1075-122X.2006.00199.x
  2. Ashikaga T, Krag DN, Land SR, et al (2010). Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol, 102, 111-8. https://doi.org/10.1002/jso.21535
  3. Balch CM, Singletary SE, Bland KI (1993). Clinical decision-making in early breast cancer. Ann Surg, 217, 207-25.
  4. Bai YL, Zhou B, Jing XY, et al (2012).Predictive Role of GSTs on the Prognosis of Breast Cancer Patients with Neoadjuvant Chemotherapy. Asian Pac J Cancer Prev, 13, 5019-22. https://doi.org/10.7314/APJCP.2012.13.10.5019
  5. Chan DN, Lui LY, So WK (2010). Effectiveness of exercise programmes on shoulder mobility and lymphoedema after axillary lymph node dissection for breast cancer: systematic review. J Adv Nurs, 66, 1902-14.
  6. Deckers PJ (1991). Axillary dissection in breast cancer: when, why, how much, and for how long? Another operation soon to be extinct? J Surg Oncol, 48, 217-9. https://doi.org/10.1002/jso.2930480402
  7. Dees EC, Shulman LN, Souba WW, et al (1997). Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? An algorithm for assessment of impact of axillary dissection. Ann Surg, 226, 279-86. https://doi.org/10.1097/00000658-199709000-00007
  8. Eberlein TJ (1994). Current management of carcinoma of the breast. Ann Surg, 220, 121-36. https://doi.org/10.1097/00000658-199408000-00003
  9. Fisher B, Anderson S, Redmond CK, et al (1995). Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med, 333, 1456-61. https://doi.org/10.1056/NEJM199511303332203
  10. Fisher B, Bauer M, Wickerham DL, et al (1983). Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: An NSABP update. Cancer, 52, 1551-7. https://doi.org/10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3
  11. Fisher B, Jeong JH, Anderson S, et al (2002). Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med, 347, 567-75. https://doi.org/10.1056/NEJMoa020128
  12. Fisher B, Redmond C, Fisher ER, et al (1985). Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med, 312, 674-81. https://doi.org/10.1056/NEJM198503143121102
  13. Fisher B, Wolmark N, Bauer M, et al (1981). The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet, 152, 765-72.
  14. Halsted WS (1907). The results of radical operations for the cure of cancer of the breast. Ann Surg, 46, 1-5. https://doi.org/10.1097/00000658-190707000-00001
  15. Harris JR, Osteen RT (1985). Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat, 5, 17-21. https://doi.org/10.1007/BF01807645
  16. IBCSG, Rudenstam CM, Zahrieh D, et al (2006). Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International. J Clin Oncol, 4, 337-40.
  17. Gardner B, Feldman J (1993). Are positive axillary nodes in breast cancer markers for incurable disease? Ann Surg, 218, 270-8. https://doi.org/10.1097/00000658-199309000-00006
  18. Krag DN, Anderson SJ, Julian TB, et al (2010). Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol, 11, 927-33. https://doi.org/10.1016/S1470-2045(10)70207-2
  19. Liljegren G, Holmberg L (1997). Arm morbidity after sector resection and axillary dissection with and without postoperative radiotherapy in breast cancer stage I: Results from a randomized trial. Uppsala-Orebro Breast Cancer Study Group. Eur J Cancer, 33, 193-9. https://doi.org/10.1016/S0959-8049(96)00375-9
  20. Lythgoe JP, Palmer MK (1982). Manchester regional breast study ? 5 and 10 year results. Br J Surg, 69, 693-6. https://doi.org/10.1002/bjs.1800691202
  21. Martelli G, Boracchi P, De Palo M, et al (2005). Randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up. Ann Surg, 242, 1-6. https://doi.org/10.1097/01.sla.0000167759.15670.14
  22. NIH consensus conference (1991). Treatment of early-stage breast cancer. JAMA, 265, 391-4. https://doi.org/10.1001/jama.1991.03460030097037
  23. Parmigiani G, Berry DA, Winer EP, et al (1999). Is axillary lymph node dissection indicated for early stage breast cancer? A decision analysis. J Clin Oncol, 17, 1465-73.
  24. Pepels MJ, Vestjens JH, de Boer M, et al (2011). Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review. Breast Cancer Res Treat, 125, 301-13. https://doi.org/10.1007/s10549-010-1210-7
  25. Ribeiro GG, Magee B, Swindell R, et al (1993). The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol (R Coll Radiol), 5, 278-83. https://doi.org/10.1016/S0936-6555(05)80900-8
  26. Ruffin WK, Stacey-Clear A, Younger J, et al (1995). Rationale for routine axillary dissection in carcinoma of the breast. J Am Coll Surg, 180, 245-51.
  27. Siesling S, van Dijck JA, Visser O, et al (2003). Trends in incidence of and mortality from cancer in The Netherlands in the period 1989-1998. Eur J Cancer, 39, 2521-30. https://doi.org/10.1016/S0959-8049(03)00622-1
  28. Silverstein MJ, Gierson ED, Waisman JR, et al (1994). Axillary lymph node dissection for T1a breast carcinoma: Is it indicated? Cancer, 73, 664 -7. https://doi.org/10.1002/1097-0142(19940201)73:3<664::AID-CNCR2820730326>3.0.CO;2-S
  29. Smith JA 3rd, Gamez-Araujo JJ, Gallager HS, et al (1990). Carcinoma of the breast: analysis of total lymph node involvement versus level of metastasis. Cancer, 39, 527-32.
  30. Sofi GN, Sofi JN, Nadeem R, et al (2012). Estrogen receptor and Progesterone Receptor Status in Brast Cancer in Relation to Age, Histological Grade, Size of Lesion and Lymph Node Involvement. Asian Pac J Cancer Prev, 13, 5047-52. https://doi.org/10.7314/APJCP.2012.13.10.5047
  31. Tian JH, Li L, Liu AP, et al (2012). Same Topic of systematic Reviews,Same Conclusion? Asian Pac J Cancer Prev, 13, 5325. https://doi.org/10.7314/APJCP.2012.13.10.5325
  32. Veronesi U, Paganelli G, Viale G, et al (2003). A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med, 349, 546-53. https://doi.org/10.1056/NEJMoa012782

Cited by

  1. Meta-analysis to determine the clinical impact of axillary lymph node dissection in the treatment of invasive breast cancer vol.153, pp.2, 2015, https://doi.org/10.1007/s10549-015-3549-2
  2. Does the number of removed axillary lymphnodes in high risk breast cancer patients influence the survival? vol.19, pp.1, 2019, https://doi.org/10.1186/s12885-019-5292-2